Efficacy and safety of gefitinib as monotherapy for Chinese patients with advanced non-small cell lung cancer.
- Author:
Meng-zhao WANG
1
;
Long-yun LI
;
Shu-lan WANG
;
Xiao-tong ZHANG
;
Wei ZHONG
;
Li ZHANG
Author Information
1. Department of Respiratory Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China.
- Publication Type:Journal Article
- MeSH:
Adult;
Aged;
Antineoplastic Agents;
therapeutic use;
Carcinoma, Non-Small-Cell Lung;
drug therapy;
mortality;
Female;
Humans;
Lung Neoplasms;
drug therapy;
mortality;
Male;
Middle Aged;
Quinazolines;
adverse effects;
therapeutic use
- From:
Chinese Medical Journal
2006;119(1):63-68
- CountryChina
- Language:English
